Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Indolobenzazepine HCV NS5B inhibitors

Indolobenzazepine HCV NS5B inhibitors

US Patent 7473688 · Granted Jan 6, 2009

Estimated economic value: $111,379,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

1H-benzo[D]imidazole derivatives as TLR9 inhibitors for the treatment of fibrosi2025
Imidazo[1,2-A]pyridine and [1,2,4]triazolo[1,5-A]pyridine derivatives as TLR9 in2025
Human CD47-targeting single-domain antibody and use thereof2025
Galectin-3 inhibitors2025
Small molecule inhibitors of galectin-32025
Small molecule inhibitors of galectin-32025
Small molecule inhibitors of galectin-32025
Small molecule inhibitors of Galectin-32025
Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitors2024
Substituted bicyclic compounds useful as T cell activators2024
Substituted bicyclic compounds useful as T cell activators2024
Method for synthesis of 2-methyl-2-hydroxyheptane and 2-methyl 2-alkoxyheptanes2024